| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to using Mycobacterium w for treating desmocollin-3 expressing cancer. Mycobacterium w is administered into mammals suffering desmocollin-3 expressing cancers.EFFECT: administering Mycobacterium w leads to cancer control and statistically adequate increase of a survival rate, and a prolonged remission of more than 15 months Mycobacterium w is also applicable as necessary together with another therapeutic agent (therapeutic agents) and/or modalities.6 cl, 3 dwg, 4 tbl, 6 ex |
